STOCK TITAN

Co-Diagnostics Inc - CODX STOCK NEWS

Welcome to our dedicated news page for Co-Diagnostics (Ticker: CODX), a resource for investors and traders seeking the latest updates and insights on Co-Diagnostics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Co-Diagnostics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Co-Diagnostics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.56%
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.76%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.72%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.97%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.63%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.64%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.87%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.4%
Tags
none
Co-Diagnostics Inc

Nasdaq:CODX

CODX Rankings

CODX Stock Data

34.70M
30.41M
2.68%
15.79%
1.12%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Salt Lake City

About CODX

co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are